Cipan Companhia Industrial Produtora de Antibioticos SACPN:LIS

0.13
0.00 / 0.00%
0
85.71%
-0.5015
Close in EURToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Oct 29 2014 15:30 GMT.

Summary

On Wednesday, Cipan Companhia Industrial Produtora de Antibioticos SA (CPN:LIS) closed at 0.13, 31.58% below its 52-week high of 0.19, set on Mar 21, 2014.

52-week range
Today
0.070
Nov 19 2013
0.19
Mar 21 2014
Open0.00
Day high--
Day low--
Bid0.12
Offer0.15
Previous close0.13
Average volume261
Shares outstanding24.45m
Free float24.45m
P/E (TTM)--
Market cap3.18m EUR
EPS (TTM)--
Data delayed at least 15 minutes, as of Oct 29 2014 15:30 GMT.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Cipan Companhia Industrial Produtora de Antibioticos SA+8.33%0.00%+18.18%+85.71%-69.77%
EURONEXT LISBON PSI 20 INDEX-1.76%-10.79%-31.33%-18.91%-38.61%
Data delayed at least 15 minutes, as of Oct 29 2014 15:30 GMT.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.